Trial Profile
A study to evaluate the efficacy and safety of Tolvaptan and Carperitide in HF patients
Status:
Not yet recruiting
Phase of Trial:
Phase II
Latest Information Update: 02 Jul 2012
Price :
$35
*
At a glance
- Drugs Tolvaptan (Primary) ; Carperitide
- Indications Acute heart failure
- Focus Therapeutic Use
- 02 Jul 2012 New trial record